Potential Interplay between Dietary Saturated Fats and Genetic Variants of the NLRP3 Inflammasome to Modulate Insulin Resistance and Diabetes Risk: Insights from a Meta-Analysis of 19 005 Individuals

Mol Nutr Food Res. 2019 Nov;63(22):e1900226. doi: 10.1002/mnfr.201900226. Epub 2019 Sep 12.

Abstract

Scope: Insulin resistance (IR) and inflammation are hallmarks of type 2 diabetes (T2D). The nod-like receptor pyrin domain containing-3 (NLRP3) inflammasome is a metabolic sensor activated by saturated fatty acids (SFA) initiating IL-1β inflammation and IR. Interactions between SFA intake and NLRP3-related genetic variants may alter T2D risk factors.

Methods: Meta-analyses of six Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (n = 19 005) tested interactions between SFA and NLRP3-related single-nucleotide polymorphisms (SNPs) and modulation of fasting insulin, fasting glucose, and homeostasis model assessment of insulin resistance.

Results: SFA interacted with rs12143966, wherein each 1% increase in SFA intake increased insulin by 0.0063 IU mL-1 (SE ± 0.002, p = 0.001) per each major (G) allele copy. rs4925663, interacted with SFA (β ± SE = -0.0058 ± 0.002, p = 0.004) to increase insulin by 0.0058 IU mL-1 , per additional copy of the major (C) allele. Both associations are close to the significance threshold (p < 0.0001). rs4925663 causes a missense mutation affecting NLRP3 expression.

Conclusion: Two NLRP3-related SNPs showed potential interaction with SFA to modulate fasting insulin. Greater dietary SFA intake accentuates T2D risk, which, subject to functional validation, may be further elaborated depending on NLRP3-related genetic variants.

Keywords: Cohorts for Heart and Ageing Research in Genomic Epidemiology consortium; NLRP3 inflammasomes; genome-wide interaction studies; insulin resistance; meta-analyses; saturated fats.

Publication types

  • Meta-Analysis
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus, Type 2 / etiology*
  • Dietary Fats / administration & dosage*
  • Genetic Variation
  • Humans
  • Inflammasomes / genetics*
  • Insulin Resistance*
  • NLR Family, Pyrin Domain-Containing 3 Protein / genetics*
  • Polymorphism, Single Nucleotide*

Substances

  • Dietary Fats
  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein